NCT01101594 · Interventional trial
A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Multiple Myeloma
Delaware Valley sites
- University Hospital of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory